Biomedcode’s human TNF transgenic arthritis model, (Tg197), contributes to the non-clinical assessment of adalimumab biosimilar GP2017 with originator Humira. Read More
Biomedcode is pleased to announce that it has received national funding from the General Secretary for Research and Technology supporting the innovative research network BreastCaRANKL that combines the efforts of industrial and renowned academic partners to develop precision drug evaluation tools for the preclinical development of novel therapies for Breast Cancer. Read More